Human Molecular Genetics, 1999, Vol. 8, No. 7 1227-1236
© 1999 Oxford University Press
Ultrastructural localization and progressive formation of neuropil aggregates in Huntington’s disease transgenic mice
Department of Genetics, Emory University, School of Medicine, 1462 Clifton Road NE, Atlanta, GA 30322, USA and 1Division of Medical and Molecular Genetics, King’s College, Guy’s Hospital, London SE1 9RT, UK
How aggregates of polyglutamine proteins are involved in the neurological symptoms of glutamine repeat diseases is unknown. We show that huntingtin aggregates are present in the neuronal processes of transgenic mice that express exon 1 of the Huntington’s disease (HD) gene. Unlike aggregates in the nucleus, these neuropil aggregates are usually smaller and are not ubiquitinated. Electron microscopy reveals many neuropil aggregates in axons and axon terminals. Huntingtin aggregates in the axon terminal are co-localized with some synaptic vesicles, implying that they may affect synaptic transmission and neuronal communication. The formation of neuropil aggregates is highly correlated with the development of neurological symptoms. The present study raises the possibility that neuropil aggregates may cause a dysfunction in neuronal communication and contribute to the neurological symptoms of HD.
a To whom correspondence should be addressed. Tel: +1 404 727 3290; Fax: +1 404 727 3949; Email: xiaoli{at}genetics.emory.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-E. Wang, H. Zhou, J. R. McGuire, V. Cerullo, B. Lee, S.-H. Li, and X.-J. Li Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin J. Cell Biol., October 20, 2008; 181(5): 803 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, C.-E. Wang, A. Orr, S. Tydlacka, S.-H. Li, and X.-J. Li Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice J. Cell Biol., March 24, 2008; 180(6): 1177 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zourlidou, T. Gidalevitz, M. Kristiansen, C. Landles, B. Woodman, D. J. Wells, D. S. Latchman, J. de Belleroche, S. J. Tabrizi, R. I. Morimoto, et al. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation Hum. Mol. Genet., May 1, 2007; 16(9): 1078 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Li, E. S. Chevalier-Larsen, D. E. Merry, and M. I. Diamond Soluble Androgen Receptor Oligomers Underlie Pathology in a Mouse Model of Spinobulbar Muscular Atrophy J. Biol. Chem., February 2, 2007; 282(5): 3157 - 3164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Benn, C. Landles, H. Li, A. D. Strand, B. Woodman, K. Sathasivam, S.-H. Li, S. Ghazi-Noori, E. Hockly, S. M.N.N. Faruque, et al. Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease Hum. Mol. Genet., October 15, 2005; 14(20): 3065 - 3078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bjorkqvist, M. Fex, E. Renstrom, N. Wierup, A. Petersen, J. Gil, K. Bacos, N. Popovic, J.-Y. Li, F. Sundler, et al. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis Hum. Mol. Genet., March 1, 2005; 14(5): 565 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Li and X.-J. Li Huntington and its Role in Neuronal Degeneration Neuroscientist, October 1, 2004; 10(5): 467 - 475. [Abstract] [PDF]
|
|
|
|
|
|
G. Schilling, A. V. Savonenko, A. Klevytska, J. L. Morton, S. M. Tucker, M. Poirier, A. Gale, N. Chan, V. Gonzales, H. H. Slunt, et al. Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice Hum. Mol. Genet., August 1, 2004; 13(15): 1599 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Hay, K. Sathasivam, S. Tobaben, B. Stahl, M. Marber, R. Mestril, A. Mahal, D. L. Smith, B. Woodman, and G. P. Bates Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach Hum. Mol. Genet., July 1, 2004; 13(13): 1389 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. M. Lee, M. Yoshihara, and J. T. Littleton Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease PNAS, March 2, 2004; 101(9): 3224 - 3229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Michalik and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet., October 15, 2003; 12(90002): R173 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, T. Wyman, Z.-X. Yu, S.-H. Li, and X.-J. Li Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release Hum. Mol. Genet., August 15, 2003; 12(16): 2021 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. von Horsten, I. Schmitt, H. P. Nguyen, C. Holzmann, T. Schmidt, T. Walther, M. Bader, R. Pabst, P. Kobbe, J. Krotova, et al. Transgenic rat model of Huntington's disease Hum. Mol. Genet., March 15, 2003; 12(6): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Wellington, L. M. Ellerby, C.-A. Gutekunst, D. Rogers, S. Warby, R. K. Graham, O. Loubser, J. van Raamsdonk, R. Singaraja, Y.-Z. Yang, et al. Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease J. Neurosci., September 15, 2002; 22(18): 7862 - 7872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Menalled, J. D. Sison, Y. Wu, M. Olivieri, X.-J. Li, H. Li, S. Zeitlin, and M.-F. Chesselet Early Motor Dysfunction and Striosomal Distribution of Huntingtin Microaggregates in Huntington's Disease Knock-In Mice J. Neurosci., September 15, 2002; 22(18): 8266 - 8276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Keene, C. M. P. Rodrigues, T. Eich, M. S. Chhabra, C. J. Steer, and W. C. Low Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease PNAS, August 6, 2002; 99(16): 10671 - 10676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. de Almeida, C. A. Ross, D. Zala, P. Aebischer, and N. Deglon Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length J. Neurosci., May 1, 2002; 22(9): 3473 - 3483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zabel, D. C. Chamrad, J. Priller, B. Woodman, H. E. Meyer, G. P. Bates, and J. Klose Alterations in the Mouse and Human Proteome Caused by Huntington's Disease Mol. Cell. Proteomics, May 1, 2002; 1(5): 366 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Lovestone and D M McLoughlin Protein aggregates and dementia: is there a common toxicity? J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 152 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Martin-Aparicio, A. Yamamoto, F. Hernandez, R. Hen, J. Avila, and J. J. Lucas Proteasomal-Dependent Aggregate Reversal and Absence of Cell Death in a Conditional Mouse Model of Huntington's Disease J. Neurosci., November 15, 2001; 21(22): 8772 - 8781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, S.-H. Li, Z.-X. Yu, P. Shelbourne, and X.-J. Li Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice J. Neurosci., November 1, 2001; 21(21): 8473 - 8481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Parker, J. B. Connolly, C. Wellington, M. Hayden, J. Dausset, and C. Neri Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death PNAS, October 25, 2001; (2001) 231476398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sathasivam, B. Woodman, A. Mahal, F. Bertaux, E. E. Wanker, D. T. Shima, and G. P. Bates Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients Hum. Mol. Genet., October 1, 2001; 10(21): 2425 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Peel, R. V. Rao, B. A. Cottrell, M. R. Hayden, L. M. Ellerby, and D. E. Bredesen Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue Hum. Mol. Genet., July 1, 2001; 10(15): 1531 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Petersen, K. E. Larsen, G. G. Behr, N. Romero, S. Przedborski, P. Brundin, and D. Sulzer Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration Hum. Mol. Genet., June 1, 2001; 10(12): 1243 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Meriin, K. Mabuchi, V. L. Gabai, J. A. Yaglom, A. Kazantsev, and M. Y. Sherman Intracellular Aggregation of Polypeptides with Expanded Polyglutamine Domain Is Stimulated by Stress-activated Kinase MEKK1 J. Cell Biol., May 14, 2001; 153(4): 851 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Adachi, A. Kume, M. Li, Y. Nakagomi, H. Niwa, J. Do, C. Sang, Y. Kobayashi, M. Doyu, and G. Sobue Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death Hum. Mol. Genet., May 1, 2001; 10(10): 1039 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Lecerf, T. L. Shirley, Q. Zhu, A. Kazantsev, P. Amersdorfer, D. E. Housman, A. Messer, and J. S. Huston Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease PNAS, April 10, 2001; 98(8): 4764 - 4769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Lin, S. Tallaksen-Greene, W.-M. Chien, J. A. Cearley, W. S. Jackson, A. B. Crouse, S. Ren, X.-J. Li, R. L. Albin, and P. J. Detloff Neurological abnormalities in a knock-in mouse model of Huntington's disease Hum. Mol. Genet., January 1, 2001; 10(2): 137 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Becker, E. Martin, J. Schneikert, H. F. Krug, and A. C.B. Cato Cytoplasmic Localization and the Choice of Ligand Determine Aggregate Formation by Androgen Receptor with Amplified Polyglutamine Stretch J. Cell Biol., April 17, 2000; 149(2): 255 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Cummings and H. Y. Zoghbi Fourteen and counting: unraveling trinucleotide repeat diseases Hum. Mol. Genet., April 1, 2000; 9(6): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Marsh, H. Walker, H. Theisen, Y.-Z. Zhu, T. Fielder, J. Purcell, and L. M. Thompson Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila Hum. Mol. Genet., January 1, 2000; 9(1): 13 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Narain, A. Wyttenbach, J. Rankin, R. A Furlong, and D. C Rubinsztein A molecular investigation of true dominance in Huntington's disease J. Med. Genet., October 1, 1999; 36(10): 739 - 746. [Abstract] [Full Text]
|
|
|
|
|
|
A. Kazantsev, E. Preisinger, A. Dranovsky, D. Goldgaber, and D. Housman Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells PNAS, September 28, 1999; 96(20): 11404 - 11409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Peters and C. A. Ross Isolation of a 40-kDa Huntingtin-associated Protein J. Biol. Chem., January 26, 2001; 276(5): 3188 - 3194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Parker, J. B. Connolly, C. Wellington, M. Hayden, J. Dausset, and C. Neri Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death PNAS, November 6, 2001; 98(23): 13318 - 13323. [Abstract] [Full Text] [PDF]
|
|